Northwest Biotherapeutics announces $5M convertible note and $50M standby equity facility

NORTHWEST BIOTHERAPEUTICS INC

Entered $5M convertible promissory note with Yorkville, 13-month term, 7% original issue discount, no interest.
Conversion at small discount to market price; limited to 1/6 of note per month unless conversion price above $0.315.
Standby equity subscription agreement allows company to require Yorkville to buy up to $50M of common shares after note repaid/converted.
Standby facility has 24-month term; no obligation to draw; company can cancel anytime after note repaid/converted.
Proceeds for general corporate purposes; Joseph Gunnar & Co. acted as exclusive placement agent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.